![Timothy Pigot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Pigot
Corporate Officer/Principal chez
INHIBIKASE THERAPEUTICS, INC.
Profil
Timothy J Pigot is Chief Commercial & Strategy Officer at Inhibikase Therapeutics, Inc. since 2025.
Formerly, Mr. Pigot was Chief Commercial Officer at Jade Biosciences, Inc. from 2021 to 2024.
Education includes undergraduate studies at State University of New York at Binghamton.
Postes actifs de Timothy Pigot
| Sociétés | Poste | Début |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Corporate Officer/Principal | 19/08/2025 |
Anciens postes connus de Timothy Pigot
| Sociétés | Poste | Fin |
|---|---|---|
| JADE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/08/2024 |
| JADE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Formation de Timothy Pigot
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
